It’s Not All Negative: Antibody Drug Conjugates in HER-2 Low Breast Cancer
Manage episode 387930466 series 2908322
Brianna Chambers, PharmD describes the landscape for HER-2 low classification in the treatment of breast cancer.
For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.
You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
101 episoder